OrthoPediatrics (KIDS) Tops Q2 EPS by 18c ; Offers Guidance

OrthoPediatrics (NASDAQ: KIDS) reported Q2 EPS of ($0.11), $0.18 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $61.1 million versus the consensus estimate of $61.39 million.

GUIDANCE:

OrthoPediatrics sees FY2025 revenue of $237-242 million, versus the consensus of $239.4 million.

For earnings history and earnings-related data on OrthoPediatrics (KIDS) click here.

You May Also Be Interested In

• INVO Fertility (IVF) Tops Q2 EPS by 105c
• Eco Wave Power reports April and May 2026 output from Jaffa Port
• VivoPower plans separate listing for 2.2GW non-Nordic AI platform